IP Library Granted Patent US 10,829,803
Granted Patent B2
US 10,829,803 · App. 11/801,990 · Granted Nov 10, 2020

Detection of nucleic acid targets using chemically reactive oligonucleotide probes

Inventor: Robert Terbrueggen (Manhattan Beach, CA)
Assignee: DXTERITY DIAGNOSTICS INCORPORATED
C12Q1/6827C12Q1/6818C12Q1/6858Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,829,803
App. No.
11/801,990
Granted
Nov 10, 2020
Kind
B2
Abstract

The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In accordance with the invention, the presence of the target(s) of interest can be determined by measuring the presence or amount of ligated oligonucleotide product.

Claims (46)

1. A method for detecting the presence of a known target nucleic acid in a sample comprising:

a) providing a ligation substrate comprising:

i) said known target nucleic acid comprising a first target domain and an adjacent second target domain, wherein the first target domain is upstream of the second target domain;

ii) a first nucleic acid ligation probe comprising:

1) a first probe domain hybridized to said first target domain; and

2) a 5′-ligation moiety; and

iii) a second nucleic acid ligation probe comprising:

1) a second probe domain hybridized to said second target domain;

2) a 3′ ligation moiety;

wherein at least one of said first and said second ligation probes comprises an anchor sequence;

b) ligating said first and said second ligation probes in the absence of a ligase enzyme to form a ligation product;

c) capturing said ligation product on a substrate comprising a capture probe that hybridizes to said anchor sequence; and

d) detecting the presence of said ligation product thereby detecting the presence of said target nucleic acid.

2. A method according to claim 1 wherein said first and second ligation moieties form a ligation moiety pair selected from the group consisting of a) a thioester and a nucleophile and b) a dimethylamino(azobenzene) sulfonyl (DABSYL) moiety and a phosphothioate moiety.

3. A method according to claim 1 wherein said sample is selected from the group consisting of a mammalian bodily fluid and a mammalian paraffin embedded tissue sample.

4. A method according to claim 1 wherein the other of said first and second ligation probes comprises a detectable label.

5. A method according to claim 4 wherein said detectable label is a fluorophore.

6. A method according to claim 1 wherein the other of said first and second ligation probes comprises a label binding sequence, and said ligated product further comprises a label probe hybridized to said binding sequence, wherein said label probe comprises a detectable label.

7. A method according to claim 1 wherein said target nucleic acid is DNA.

8. A method according to claim 1 wherein said known target nucleic acid is RNA.

9. A method for detecting the presence of a known target nucleic acid in a sample comprising:

a) providing a ligation substrate comprising:

i) said known target nucleic acid comprising a first target domain and an adjacent second target domain, wherein the first target domain is upstream of the second target domain;

ii) a first nucleic acid ligation probe comprising:

1) a first probe domain hybridized to said first target domain; and

2) a 5′-ligation moiety; and

iii) a second nucleic acid ligation probe comprising:

1) a second probe domain hybridized to said second target domain;

2) a 3′ ligation moiety;

wherein said first and second ligation moieties form a ligation moiety pair selected from the group consisting of a) a thioester and a nucleophile and b) a dimethylamini(azobenzene) sulfonyl (DABSYL) moiety and a phosphothioate moiety, and wherein at least one of said first and said second nucleic acid ligation probes comprises an anchor sequence;

b) ligating said first and said second ligation probes in the absence of a ligase enzyme to form a ligation product;

c) capturing said ligation product on a substrate comprising a capture probe complementary to said anchor sequence; and

d) detecting the presence of said ligation product.

10. A method for detecting the presence of a known target nucleic acid in a sample, wherein said sample is selected from the group consisting of a mammalian bodily fluid and a mammalian paraffin embedded tissue sample, said method comprising:

a) providing a ligation substrate comprising:

i) said known target nucleic acid comprising a first target domain and an adjacent second target domain, wherein the first target domain is upstream of the second target domain;

ii) a first nucleic acid ligation probe comprising:

1) a first probe domain hybridized to said first target domain; and

2) a 5′-ligation moiety; and

iii) a second nucleic acid ligation probe comprising:

1) a second probe domain hybridized to said second target domain;

2) a 3′ ligation moiety;

wherein at least one of said first and said second nucleic acid ligation probes comprises an anchor sequence;

b) ligating said first and said second ligation probes in the absence of a ligase enzyme to form a ligation product;

c) capturing said ligation product on a substrate comprising a capture probe complementary to said anchor sequence; and

d) detecting the presence of said ligation product.

Assignments (5)
SECURITY INTEREST Recorded Jul 10, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 036061/0144 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2015
From: SILICON VALLEY BANK
To: DXTERITY DIAGNOSTICS
Reel/Frame 035438/0992 →
SECURITY INTEREST Recorded Apr 17, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SWK FUNDING LLC
Reel/Frame 035439/0279 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 031156/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2008
From: TERBRUEGGEN, ROBERT
To: DXTERITY DIAGNOSTICS
Reel/Frame 020368/0580 →
Continuity (2)
Provisional Application 60746897 · May 10, 2006
Related Publication 20080124810A1 · May 29, 2008
Cited By (28)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,234,505 US 12,241,060 US 12,241,890 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,297,486 US 12,297,487 US 12,297,488 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,391,979 US 12,391,980 US 12,404,544 US 12,405,264 US 12,442,045 US 12,529,094 US 12,566,113 US 12,571,029 US 12,624,475 US 12,668,835